JP2006508332A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508332A5
JP2006508332A5 JP2004507519A JP2004507519A JP2006508332A5 JP 2006508332 A5 JP2006508332 A5 JP 2006508332A5 JP 2004507519 A JP2004507519 A JP 2004507519A JP 2004507519 A JP2004507519 A JP 2004507519A JP 2006508332 A5 JP2006508332 A5 JP 2006508332A5
Authority
JP
Japan
Prior art keywords
ppsa
psa
total
amount
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004507519A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508332A (ja
Filing date
Publication date
Priority claimed from US10/154,715 external-priority patent/US20030219840A1/en
Application filed filed Critical
Publication of JP2006508332A publication Critical patent/JP2006508332A/ja
Publication of JP2006508332A5 publication Critical patent/JP2006508332A5/ja
Pending legal-status Critical Current

Links

JP2004507519A 2002-05-24 2003-05-22 前立腺癌検出改善のための血清中前立腺特異抗原プロ酵素型の分析方法。 Pending JP2006508332A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/154,715 US20030219840A1 (en) 2002-05-24 2002-05-24 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection
PCT/US2003/016148 WO2003100079A2 (en) 2002-05-24 2003-05-22 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection

Publications (2)

Publication Number Publication Date
JP2006508332A JP2006508332A (ja) 2006-03-09
JP2006508332A5 true JP2006508332A5 (enExample) 2006-05-18

Family

ID=29548943

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004507519A Pending JP2006508332A (ja) 2002-05-24 2003-05-22 前立腺癌検出改善のための血清中前立腺特異抗原プロ酵素型の分析方法。

Country Status (5)

Country Link
US (1) US20030219840A1 (enExample)
EP (1) EP1506401A4 (enExample)
JP (1) JP2006508332A (enExample)
CN (1) CN1656379A (enExample)
WO (1) WO2003100079A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111878A1 (en) * 2008-03-11 2009-09-17 Axela Inc. Quantification and affinity characterization of antibodies for the diagnosis of disease using optical diffraction
CN103134929A (zh) * 2011-12-02 2013-06-05 沃克(天津)生物科技有限公司 游离前列腺特异抗原与总前列腺特异抗原一体化酶联免疫检测试剂盒及检测方法
CN102520161A (zh) * 2012-01-05 2012-06-27 中南大学 一种用于spr双通道法检测前列腺特异性抗原的生物传感芯片、试剂盒，检测方法
RU2014150777A (ru) 2012-05-16 2016-07-10 Пхадиа Аб Способ индикации наличия или отсутствия рака предстательной железы
MY182773A (en) 2012-11-20 2021-02-05 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
CN104007256A (zh) * 2013-02-21 2014-08-27 林斯 总psa和游离psa二合一化学发光免疫诊断试剂盒的制备方法
EP4220170A3 (en) 2014-03-11 2023-12-13 Phadia AB Method for detecting a solid tumor cancer
CN105929151A (zh) * 2016-06-30 2016-09-07 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法
FI3577237T3 (fi) 2017-02-01 2023-08-29 Phadia Ab Menetelmä eturauhassyövän läsnäolon tai puuttumisen osoittamiseksi henkilöillä, joilla on tiettyjä ominaisuuksia
CN111596060A (zh) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659073B2 (en) * 1997-04-30 2010-02-09 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
JP5284554B2 (ja) * 1997-04-30 2013-09-11 ハイブリテック インコーポレイテッド 前立腺特異的抗原の形態およびその検出方法
US7211397B2 (en) * 1999-04-30 2007-05-01 Beckman Coulter, Inc. Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
WO2001090194A2 (de) * 2000-05-24 2001-11-29 Roche Diagnostics Gmbh Antikörper gegen spezielle formen des propsa und deren verwendung in immunoassays

Similar Documents

Publication Publication Date Title
O'brien et al. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals
Berglund et al. Inter-individual variations of human mercury exposure biomarkers: a cross-sectional assessment
JP2006508332A5 (enExample)
MA29282B1 (fr) Procede de diagnostic d'une steatose hepatique au moyen de marqueurs biochimiques
WO2006066274A3 (en) Breath-based sensors for non-invasive molecular detection
IL154566A0 (en) Diagnosis method of fibrotic disease using biochemical markers
WO2001061043A3 (en) Parallel genotyping of multiple patient samples
CY1109638T1 (el) Ενα συστημα ή μεθοδος για την εκτιμηση της περιφερειακης κυκλοφοριας του αιματος ενος υποκειμενου
TW200745543A (en) System and methods for providing corrected analyte concentration measurements
WO2006103570A8 (en) Diagnosis method of alcoholic or non-alcoholic steato-hepatitis using biochemical markers
ATE532063T1 (de) Elektrochemischer biosensor
SI2332582T1 (sl) Aktivacija ACE2 za zdravljenje srčne, pljučne in ledvične bolezni in hipertenzije
WO2003100006A3 (en) Method of improved prostate cancer detection
JP2015535077A (ja) デバイスおよびアミノアシドパシーの検出のためにデバイスを用いる方法
CN103760121B (zh) 一种血液中亚硝酸盐的检测方法
WO2008020823A3 (en) Cooperative reporter systems, components, and methods for analyte detection
CN104359906B (zh) 一种稳定、抗干扰能力强的血清总胆汁酸检测试剂
CA2510377A1 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
CN102095825B (zh) 超高效液相色谱和质谱联用筛选黄嘌呤氧化酶抑制剂的方法
JP2014505254A5 (enExample)
Fabris et al. Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index
EP1437591A4 (en) KITS FOR THE DIAGNOSIS OF KIDNEY DISEASES
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
JP2010500535A5 (enExample)
WO2003100079A3 (en) Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection